Tag: KROS

Stock Earnings

In a filing, Keros Therapeutics Inc revealed its Chief Financial Officer Regnante Keith unloaded Company’s shares for reported $1.81 million

Insiders Updates

Keros Therapeutics Inc’s filing revealed that its Chief Financial Officer Regnante Keith unloaded Company’s shares for reported $1.81 million on

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its